×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Non-Hodgkin Lymphoma

Ryan Hamner
A friend at the chemotherapy clinic told his story, but never said a word.
Wayne Kuznar
Axicabtagene ciloleucel had high response rates in patients with non-Hodgkin lymphoma in a phase 2 study.
Andrew J. Roth
Shannon Kerr isn't shy about proclaiming her status as a cancer survivor. At the 2016 Battlefrog Fiesta Bowl in Phoenix, Kerr was joined by a stadium full of fans in drawing attention to the disease and the toll it can take.
Kelly Johnson
Only 30 percent of survivors at high risk for cardiac damage adhered to long-term recommendations including an echocardiogram, electrocardiogram or multigated acquisition (MUGA) scan.
Peggy Thomas
I don't sign the hospitality guest book. I'm a ghost floating through the corridors. I don't want to make an impact here; don't want to call Roswell Park Cancer Institute home. But when a stranger offers comfort, I'm filled with hope.
Erin Moore
Two types of effective treatments for non-Hodgkin lymphoma are cell signaling inhibitors and monoclonal antibodies.
Laura Panjwani
CURE spoke with Bruce D. Cheson to gain a deeper understanding of adding the targeted therapy Gazyva to the chemotherapy Treanda for patients with Rituxan-refractory indolent non-Hodgkin lymphoma.
Lauren M. Green
Patients with relapsed indolent non-Hodgkin lymphoma who took the anti-CD20 agent Gazyva with Treanda, rather than Treanda alone, doubled their time until further disease progression during the phase 3 GADOLIN study.
Adam Asch, senior deputy director of Stephenson Cancer Center, gives advice to patients after they have been diagnosed with lymphoma.
Debu Tripathy, MD
Most non-Hodgkin lymphomas can be cured, but new drugs are needed.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable